- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03013764
Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function
Interaction Between Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function
Physical inactivity results in reductions in glucose tolerance and less sensitivity to insulin. If this inactivity lasts long enough it can result in insulin resistance and type 2 diabetes. A high protein diet can reduce elevated glucose levels in individuals with type 2 diabetes. Thus the investigators are interested in establishing if during a period of inactivity if a diet modification can minimize the glucose changes normally observed with inactivity. The objective of this project is to determine if short-term high protein (HP) feeding protects against the changes in glucose levels normally observed with physical inactivity. The investigators will also examine measures of blood vessel function, blood lipid and blood pressure.
Twelve subjects will complete two 10 day study periods of reduced physical activity and will be studied before and after each of these study periods. For their testing subjects will have the following measurements: postprandial glucose responses to a mixed meal, 24 h free living blood pressure control during acute physical inactivity, blood lipids, changes in body composition, changes in circadian rhythm using skin temperature (ibutton), measurement of aerobic capacity (VO2 max), blood vessel responsiveness (flow mediated dilation -FMD) and changes in free living glucose levels (continuous glucose monitoring system (CGMS). Subjects will complete two conditions (high protein -HP vs normal protein - NP diets) in a randomized cross-over design. In the inactive phase subjects will reduce there steps to <5,000 steps/d while consuming either a HP or NP diet. Completion of the study will take 8-10 weeks.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
It is well known that insulin resistance increases the risk of cardiovascular disease and type 2 diabetes, which substantially impact mortality and morbidity and presents a significant economic burden. Energy restriction with or without exercise has been demonstrated to attenuate/reverse the development of insulin resistance and reduce the risk of cardiovascular disease and type 2 diabetes. Indeed, accumulating evidence suggests that diets high in protein may possess additional protection against the development of insulin resistance during energy restriction. Layman et al. found that a high protein diet (HP) (PRO 125 g/d) compared with an isocaloric high carbohydrate diet (HCHO) (PRO 68 g/d) resulted in greater reductions in fasting glucose and 2 h postprandial insulin levels during 16 weeks of energy restriction in overweight women. Similarly, a hypocaloric high protein diet (PRO 45% vs 20%; 21 d diet treatment) increased glucose oxidation and improved insulin sensitivity compared to an isocaloric high carbohydrate diet during a euglycemic hyperinsulinemic clamp procedure. In addition, markers of inflammation, β-cell function, and postprandial glucose and insulin levels were improved in addition to increased resting energy expenditure after 6 months of hypocaloric HP compared with HCHO diet in premenopausal women independent of weight loss. The increase in REE and improvement in adipose tissue function may be a potential mechanism by which HP diet improves β-cell function since NEFAs are lower, which may reduce lipotoxicity on the pancreas.
It is evident that physical inactivity (highlighted from bed rest studies) impairs glucose tolerance, insulin sensitivity, vascular function, and muscle protein synthesis in both healthy and obese individuals. This model of inactivity, however, is extreme and does not recapitulate the physical inactivity paradigm seen in the natural human environment. Consequently, a less extreme reduction in daily physical activity (>10,000 steps/d to ~1,500 steps/d) results in significant reductions in insulin sensitivity, glucose tolerance, and insulin-stimulated muscle Akt phosphorylation, suggesting that the impairments in insulin sensitivity and glucose tolerance precede changes in body composition. A reduction in ambulatory activity is a highly valid and translatable model to study the role of inactivity on the development of metabolic disease, as most individuals go through periods of inactivity, and it has been shown that a reduction in daily steps decreases insulin sensitivity and increases visceral adiposity. To date, no study has tested the effects of diet composition on the perturbations of physical inactivity. It is important to know if increasing protein intake mitigates the negative perturbations of reduced ambulatory activity.
Thus, the overall objective of this project is to determine the extent to which short-term high protein (HP) feeding may protect against the metabolic perturbations of physical inactivity (i.e. PPG, hyperinsulinemia, and insulin sensitivity). The investigators will also examine measures of vascular function and free living blood pressure in addition to lipemic responses (i.e. FFAs, triglycerides, cholesterol, and lipoproteins) to determine if HP diet impacts vascular function and lipemic responses during short term physical inactivity.
Trial Objectives and Purpose
The specific aims of this project include the following:
Specific Aim 1: To determine if HP diet during a period of low physical activity will lower the insulin response to a meal, and help to maintain insulin sensitivity and β-cell function during a laboratory based mixed meal test (MMT) with stable isotope tracers.
Specific Aim 2: To determine if a HP diet during a period of low physical activity will maintain glycemic control measured by continuous glucose monitoring (CGM) in healthy, recreationally active, young individuals.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Missouri
-
Columbia, Missouri, États-Unis, 65211
- University of Missouri
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- BMI <28 kg/m2
- No known cardiovascular, kidney, or liver disease.
- No history of surgery for weight loss and weight stable for prior 3 months (weight change < 3 kg).
- Physically active individual (90 minutes of primarily whole body aerobic physical activity <3 days per week and taking greater than 10,000 steps per day)
- Between 18-45 yr of age.
- Participants who consume on average less than 18% of total calories as protein
Exclusion Criteria:
- History of alcohol use (< 20 g/day for males and > 10 g/day for females)
- Smoker.
- BMI < 28 kg/m2
- Kidney or liver disease.
- Physically inactive (completing < 75 min of whole body aerobic activity <3 times per week or obtaining <10,000 steps/day)
- Pregnant or lactating
- <18 or >45 yr of age
- High protein consumers (>20% of total daily calories as protein)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Non randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur placebo: normal protein intake
subjects will undergo 10 days of low physical activity while consuming a normal protein diet
|
subjects will undergo 10 days of low physical activity while consuming a normal protein diet
|
|
Expérimental: high protein intake
subjects will undergo 10 days of low physical activity while consuming a high protein diet
|
subjects will undergo 10 days of low physical activity while consuming a high protein diet
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
glucose excursions
Délai: change in from baseline
|
change in from baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
insulin sensitivity
Délai: change in from baseline
|
change in from baseline
|
|
blood lipids
Délai: change in from baseline
|
change in from baseline
|
|
insulin, FFA and other hormones (e.g. glucagon, adropin, etc)
Délai: change in from baseline
|
change in from baseline
|
|
endothelial function
Délai: change in from baseline
|
change in from baseline
|
|
beta cell function
Délai: change in from baseline
|
change in from baseline
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- American Egg Board - 00050021
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Inactivité physique
-
Busra Kalkan BalakComplétéVolontaires en bonne santé | Physical Fitness (G11.427.410.698)Turquie (Türkiye)
-
University of Castilla-La ManchaPas encore de recrutementFatigue musculaire (C23.888.592.612.612) | Blessures sportives (C26.857.500.124) | Récupération de la fonction (G11.427.698.620) | Cryothérapie (E02.095.301.250) | Thermothérapie (E02.095.301.750) | Soccer (I03.450.642.845.750) | Biomarqueurs (D23.050.301) | Thermographie (E01.370.350.700.750) | Physical...
Essais cliniques sur normal protein diet
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyComplétéSclérose en plaquesÉtats-Unis
-
Ondokuz Mayıs UniversityInscription sur invitationÉvaluation nutritionnelle | Intervention nutritionnelle | SOPK - Syndrome des ovaires polykystiquesTurquie (Türkiye)
-
Mondelēz International, Inc.KGK Science Inc.Complété
-
Prof. Lutfu Hanoglu, MDComplétéMaladie d'Alzheimer (MA) | Démence de type AlzheimerTurquie (Türkiye)
-
Thomas Jefferson UniversityComplété
-
Utah State UniversityGreenAcres FoundationActif, ne recrute pasRéaction inflammatoireÉtats-Unis
-
Istanbul Medipol University HospitalComplétéLa maladie de Parkinson | ParkinsonTurquie
-
Icahn School of Medicine at Mount SinaiUniversity of Massachusetts, Worcester; The Leona M. and Harry B. Helmsley...Actif, ne recrute pasGrossesse | Maladie de CrohnÉtats-Unis
-
University of California, Los AngelesComplétéÉtat prédiabétiqueÉtats-Unis
-
Prof. Dr. med. Andreas F. H. PfeifferEuropean UnionComplété